AMYRA is developing a unique enzyme combination for curative care of Celiac Disease and Non-Celiac Gluten Sensitivity (NCGS), which represent major public health issues.

AMYRA’s products have the potential to establish the standard of care and majorly impact the lives of affected people.

Location

Malzgasse 9, 4052 Basel, Switzerland

Facts & figures
  • Type of organization

    Private company

  • Year of foundation

    2013

  • Number of employees in Switzerland

    1-9

Key business